Top

Published in:

Open Access 01-12-2014 | Meeting abstract

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study

Authors: P Goadsby, D Dodick, E Spierings, J Scherer, S Sweeney, D Grayzel

Excerpt

Migraine remains poorly treated with few effective preventive medications available. …

Title: EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
Authors: P Goadsby
D Dodick
E Spierings
J Scherer
S Sweeney
D Grayzel
Publication date: 01-12-2014
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/1129-2377-15-S1-G10